These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2576826)
1. A potential mechanism underlying the voluntary suppression of tardive dyskinesia. Caligiuri MP; Lohr JB J Psychiatr Res; 1989; 23(3-4):257-66. PubMed ID: 2576826 [TBL] [Abstract][Full Text] [Related]
2. Quantitative analyses of voluntary orofacial motor control in schizophrenia and tardive dyskinesia. Caligiuri MP; Harris MJ; Jeste DV Biol Psychiatry; 1988 Nov; 24(7):787-800. PubMed ID: 2906545 [TBL] [Abstract][Full Text] [Related]
3. Fine force instability: a quantitative measure of neuroleptic-induced dyskinesia in the hand. Caligiuri MP; Lohr JB J Neuropsychiatry Clin Neurosci; 1990; 2(4):395-8. PubMed ID: 1983784 [TBL] [Abstract][Full Text] [Related]
4. Tardive dyskinesia: current clinical issues. Burke RE Neurology; 1984 Oct; 34(10):1348-53. PubMed ID: 6148718 [TBL] [Abstract][Full Text] [Related]
5. Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis. Apud JA; Egan MF; Wyatt RJ Schizophr Res; 2003 Sep; 63(1-2):151-60. PubMed ID: 12892869 [TBL] [Abstract][Full Text] [Related]
6. Motor mechanisms in schizophrenic patients with tardive dyskinesia. Vrtunski PB; Alphs LD; Meltzer HY Psychiatry Res; 1994 Oct; 54(1):71-86. PubMed ID: 7701030 [TBL] [Abstract][Full Text] [Related]
7. A disturbance in the control of muscle force in neuroleptic-naive schizophrenic patients. Caligiuri MP; Lohr JB Biol Psychiatry; 1994 Jan; 35(2):104-11. PubMed ID: 7909452 [TBL] [Abstract][Full Text] [Related]
8. Treatment of tardive dyskinesia with donepezil: a pilot study. Caroff SN; Campbell EC; Havey J; Sullivan KA; Mann SC; Gallop R J Clin Psychiatry; 2001 Oct; 62(10):772-5. PubMed ID: 11816865 [TBL] [Abstract][Full Text] [Related]
9. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs]. Seigneurie AS; Sauvanaud F; Limosin F Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134 [TBL] [Abstract][Full Text] [Related]
10. The natural history of tardive dyskinesia. Gardos G; Cole JO; Haskell D; Marby D; Paine SS; Moore P J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):31S-37S. PubMed ID: 2906068 [TBL] [Abstract][Full Text] [Related]
11. Early course of new-onset tardive dyskinesia in older patients. Lacro JP; Gilbert PL; Paulsen JS; Fell R; Bailey A; Juels C; Caligiuri M; McAdams LA; Harris MJ; Jeste DV Psychopharmacol Bull; 1994; 30(2):187-91. PubMed ID: 7831454 [TBL] [Abstract][Full Text] [Related]
12. Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials. Lockwood JT; Remington G Expert Opin Emerg Drugs; 2015 Sep; 20(3):407-21. PubMed ID: 26166007 [TBL] [Abstract][Full Text] [Related]
13. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study. Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962 [TBL] [Abstract][Full Text] [Related]